onc Videos

Videos

Nataliya Uboha, MD, PhD, University of Wisconsin

Videos

Biomarker Testing and Targeted Treatments for Gastroesophageal Cancers

03/30/2023

At the 2023 Great Debates and Updates in Gastrointestinal Malignancies in Chicago, Nataliya Uboha, MD, PhD, gave an overview of her presentation on biomarkers and targeting treatment for gastroesophageal cancers.

At the 2023 Great Debates and...

03/30/2023

Oncology

Videos

Treating a Patient With Unmutated IGHV, ATM-Deleted Chronic Lymphocytic Leukemia

03/27/2023

Talha Munir, MD, St. James's Hospital in Leeds, United Kingdom, highlights his treatment choices for the case of a 76-year-old patient with chronic lymphocytic leukemia.

Talha Munir, MD, St. James's...

03/27/2023

Oncology

Brian Slomovitz, MD, Mount Sinai Medical Center, Miami, FL

Videos

Letrozole Plus Ribociclib in Low-Grade Serous Ovarian Cancer

03/26/2023

Brian Slomovitz, MD, discusses his presentation on the use of letrozole plus ribociclib for patients with recurrent low-grade serous carcinoma of the ovaries at the SGO Annual Meeting on Women's Cancer.

Brian Slomovitz, MD, discusses...

03/26/2023

Oncology

Tim Pawlik, MD, PhD, MPH, James Cancer Center

Videos

Targeting IDH and FGFR Mutations for Cholangiocarcinoma

03/25/2023

Timothy Pawlik, MD, PhD, MPH, gives an overview of IDH and FGFR mutations as molecular targets for cholangiocarcinoma.

Timothy Pawlik, MD, PhD, MPH,...

03/25/2023

Oncology

Manisha Palta, MD, Duke University Cancer Center

Videos

An Argument for Radiation in the Neoadjuvant Setting for Pancreatic Cancer

03/23/2023

At the 2023 ACRO Radiation Oncology Summit, Manisha Palta, MD, discussed the role of radiation therapy in the neoadjuvant setting for patients with pancreatic cancer.

At the 2023 ACRO Radiation...

03/23/2023

Oncology

Gerard Morton, MD, Odette Cancer Center at Sunnybrook Research Institute

Videos

Methods of Radiation Dose Intensification for High-Risk Prostate Cancer

03/21/2023

At the 2023 ACRO Radiation Oncology Summit, Gerard Morton, MD, discusses the different methods of radiation dose intensification for patients with high-risk prostate cancer.

At the 2023 ACRO Radiation...

03/21/2023

Oncology

Mylin Torres, MD, Winship Cancer Institute

Videos

Five-Fraction Radiation Regimens for Early-Stage Breast Cancer

03/20/2023

At the 2023 ACRO Radiation Oncology Summit, Mylin Torres, MD, gave a presentation exploring the option of 5-fraction radiation regimens for patients with early-stage breast cancer.

At the 2023 ACRO Radiation...

03/20/2023

Oncology

Maria Werner-Wasik, MD, Sidney Kimmel Cancer Center

Videos

Chemoimmunotherapy and the Changing Landscape of Preoperative Treatment for Stage III Non-Small Cell Lung Cancer

03/20/2023

At the 2023 ACRO Radiation Oncology Summit, Maria Werner-Wasik, MD, discussed preoperative treatment options for stage III non-small cell lung cancer.

At the 2023 ACRO Radiation...

03/20/2023

Oncology

Videos

How Preoperative Chemoimmunotherapy May Change Management of Patients With Stage III Non-Small Cell Lung Cancer

03/20/2023

At the 2023 ACRO Radiation Oncology Summit, Maria Werner-Wasik, MD, discussed preoperative treatment options for stage III non-small cell lung cancer.

At the 2023 ACRO Radiation...

03/20/2023

Oncology

Hyman Muss, MD, Linberger Cancer Center at the University of North Carolina, Chapel Hill, NC

Videos

Management of Older Patients With Breast Cancer

03/17/2023

Hyman Muss, MD, outlines the important considerations for providers caring for older patients with breast cancer.

Hyman Muss, MD, outlines the...

03/17/2023

Oncology

Recent News

News

Osimertinib Lacks Activity in Neoadjuvant Setting for Early-Stage Non-Small Cell Lung Cancer With EGFR Mutation

08/08/2024

Stephanie Holland ;

Results from a phase 2 study demonstrated that neoadjuvant osimertinib did not improve the major pathological response rate among patients with early-stage non-small cell lung cancer harboring an EGFR mutation.

Results from a phase 2 study...

08/08/2024

Oncology

FDA Approval

FDA Approves Denileukin Diftitox for Patients With R/R Cutaneous T-Cell Lymphoma

08/08/2024

Amber Denham ;

The US Food and Drug Administration approved novel immunotherapy denileukin diftitox-cxdl for the treatment of patients with relapsed/refractory cutaneous T-cell lymphoma after at least 1 prior systemic therapy.

The US Food and Drug...

08/08/2024

Oncology

News

Tailored Dose-Dense Chemotherapy Improved Survival Outcomes Among Patients With High-Risk Early Breast Cancer

08/07/2024

Stephanie Holland ;

According to results from the phase 3 PANTHER trial, tailored and dose-dense chemotherapy in the adjuvant setting improved survival outcomes compared to standard chemotherapy among patients with high-risk early breast cancer.

According to results from the...

08/07/2024

Oncology

News

Frontline Treatment Management for Patients With FL Reduces Risk of High-Grade Transformation to DLBCL

08/07/2024

Amber Denham ;

A recent study demonstrated that frontline treatment management reduced the risk of high-grade transformation to diffuse large B-cell lymphoma among patients with follicular lymphoma, but not among patients with marginal zone lymphoma.

A recent study demonstrated that...

08/07/2024

Oncology

News

Optimal Sotorasib Dose for Patients With KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer

08/07/2024

Stephanie Holland ;

Results from a phase 2 study found that 960 mg of sotorasib is preferable to 240 mg among patients with previously treated KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer.

Results from a phase 2 study...

08/07/2024

Oncology

FDA Approval

FDA Approves Vorasidenib for Patients With IDH1/IDH2-Mutated Grade 2 Astrocytoma or Oligodendroglioma

08/06/2024

Stephanie Holland ;

Based on results from the INDIGO trial, the FDA has approved vorasidenib for adult and pediatric patients 12 years and older with grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation following surgery.

Based on results from the INDIGO...

08/06/2024

Oncology

FDA Approval

FDA Approves Afamitresgene Autoleucel for Certain Unresectable or Metastatic Synovial Sarcoma

08/02/2024

Allison Casey ;

On August 2, 2024, the US Food and Drug Administration (FDA) granted accelerated approval to afamitresgene autoleucel for the treatment of adult patients with certain unresectable or metastatic synovial sarcomas who had received prior...

On August 2, 2024, the US Food...

08/02/2024

Oncology

FDA Approval

FDA Approves Dostarlimab Plus Chemotherapy for Patients With Primary Advanced or Recurrent Endometrial Cancer

08/01/2024

Allison Casey ;

The FDA approved dostarlimab plus carboplatin and paclitaxel, followed by single-agent dostarlimab for patients with primary advanced or recurrent endometrial cancer.

The FDA approved dostarlimab...

08/01/2024

Oncology

News

Iadademstat and Azacitidine Combination Therapy Demonstrates Manageable Safety, Promising Efficacy for Patients With Newly Diagnosed AML

08/01/2024

Amber Denham ;

The first-line combination of iadademstat and azacitidine demonstrates a manageable safety profile and promising results among patients with acute myeloid leukemia, according to phase 2 results from the ALICE trial.

The first-line combination of...

08/01/2024

Oncology

News

Effect of Food on Selumetinib Dosing for Adolescent Patients With Neurofibromatosis Type 1 With Plexiform Neurofibromas

08/01/2024

Allison Casey ;

In the phase 1 trial, the addition of a low-fat meal with doses of selumetinib did not significantly impact selumetinib exposure or gastrointestinal toxicities among adolescent patients with neurofibromatosis type 1 with plexiform...

In the phase 1 trial, the...

08/01/2024

Oncology